scholarly journals A 24‐week multicentre, randomized, open‐label, parallel‐group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate‐to‐severe plaque psoriasis naive to systemic treatment

2019 ◽  
Vol 182 (4) ◽  
pp. 869-879 ◽  
Author(s):  
K. Reich ◽  
M. Augustin ◽  
D. Thaçi ◽  
A. Pinter ◽  
A. Leutz ◽  
...  
Keyword(s):  
Fumaric Acid ◽  
Plaque Psoriasis ◽  
Systemic Treatment ◽  
Efficacy And Safety ◽  
Open Label ◽  
Severe Plaque Psoriasis ◽  
Fumaric Acid Esters ◽  
Parallel Group Study ◽  
Parallel Group ◽  
Acid Esters

Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate‐to‐severe plaque psoriasis (FAST)

2017 ◽  
Vol 15 (2) ◽  
pp. 180-186 ◽  
Author(s):  
Peter Weisenseel ◽  
Kristian Reich ◽  
Wiebke Griemberg ◽  
Katharina Merten ◽  
Christine Gröschel ◽  
...  
Keyword(s):  
Fumaric Acid ◽  
Plaque Psoriasis ◽  
Efficacy And Safety ◽  
Severe Plaque Psoriasis ◽  
Fumaric Acid Esters ◽  
Acid Esters
Sign in / Sign up

Export Citation Format

Share Document